{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:17:56Z","timestamp":1790086676912,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Forensic and Legal Medicine"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.jflm.2013.02.007","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T12:18:05Z","timestamp":1362745085000},"page":"540-542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Lack of efficacy during the switch from brand to generic allopurinol"],"prefix":"10.1016","volume":"20","author":[{"given":"Antonio","family":"De Vuono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Scicchitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Palleria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovambattista","family":"De Sarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Gallelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jflm.2013.02.007_bib1","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ajg.2011.29","article-title":"The FDA's generic-drug approval process: similarities to and differences from brand-name drugs","volume":"106","author":"Kefalas","year":"2011","journal-title":"American Journal of Gastroenterology"},{"issue":"8","key":"10.1016\/j.jflm.2013.02.007_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023611","article-title":"Quality of reporting of bioequivalence trials comparing generic to brand name drugs: a methodological systematic review","volume":"6","author":"van der Meersch","year":"2011","journal-title":"Plos One"},{"issue":"2","key":"10.1016\/j.jflm.2013.02.007_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ana.22452","article-title":"Assessing bioequivalence of generic antiepilepsy drugs","volume":"70","author":"Krauss","year":"2011","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1016\/j.jflm.2013.02.007_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2125.2009.03399.x","article-title":"Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers","volume":"68","author":"Del Tacca","year":"2009","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.jflm.2013.02.007_bib5","first-page":"872","article-title":"Pharmacovigilance and drug safety 2011 in Calabria (Italy): adverse events analysis","volume":"17","author":"Scicchitano","year":"2012","journal-title":"Journal of Research in Medical Sciences"},{"issue":"5","key":"10.1016\/j.jflm.2013.02.007_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1043661802002104","article-title":"Adverse drug reactions to antibiotics observed in two pulmonology divisions of Catanzaro, Italy: a six-year retrospective study","volume":"46","author":"Gallelli","year":"2002","journal-title":"Pharmacological Research"},{"issue":"6","key":"10.1016\/j.jflm.2013.02.007_bib7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1043-6618(03)00003-3","article-title":"Retrospective analysis of adverse drug reactions to bronchodilators observed in two pulmonary divisions of Catanzaro, Italy","volume":"47","author":"Gallelli","year":"2003","journal-title":"Pharmacological Research"},{"issue":"3","key":"10.1016\/j.jflm.2013.02.007_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.phrs.2003.10.001","article-title":"Retrospective analysis of adverse drug reactions induced by gemcitabine treatment in patients with non-small cell lung cancer","volume":"49","author":"Gallelli","year":"2004","journal-title":"Pharmacological Research"},{"issue":"8","key":"10.1016\/j.jflm.2013.02.007_bib9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2165\/00044011-200424080-00007","article-title":"Levofloxacin-induced taste perversion, blurred vision and dyspnoea in a young woman","volume":"24","author":"Gallelli","year":"2004","journal-title":"Clinical Drug Investigation"},{"issue":"12","key":"10.1016\/j.jflm.2013.02.007_bib10","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1345\/aph.1E326","article-title":"Generalized exfoliative dermatitis induced by interferon alfa","volume":"38","author":"Gallelli","year":"2004","journal-title":"The Annals of Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.jflm.2013.02.007_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00044011-200525030-00008","article-title":"Melaena following use of the cholinesterase inhibitor rivastigmine","volume":"25","author":"Gareri","year":"2005","journal-title":"Clinical Drug Investigation"},{"issue":"6","key":"10.1016\/j.jflm.2013.02.007_bib12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2165\/00044011-200525060-00008","article-title":"Nimesulide-induced hepatotoxicity in a previously healthy woman","volume":"25","author":"Gallelli","year":"2005","journal-title":"Clinical Drug Investigation"},{"issue":"5","key":"10.1016\/j.jflm.2013.02.007_bib13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.phrs.2005.05.013","article-title":"Increase in plasma homocysteine levels induced by drug treatments in neurologic patients","volume":"52","author":"Siniscalchi","year":"2005","journal-title":"Pharmacological Research"},{"issue":"2","key":"10.1016\/j.jflm.2013.02.007_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00044011-200727020-00004","article-title":"Retrospective evaluation of adverse drug reactions induced by nonsteroidal anti-inflammatory drugs","volume":"27","author":"Gallelli","year":"2007","journal-title":"Clinical Drug Investigation"},{"key":"10.1016\/j.jflm.2013.02.007_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.archger.2007.01.027","article-title":"Anticholinergic drug-induced delirium in an elderly Alzheimer's dementia patient","volume":"44","author":"Gareri","year":"2007","journal-title":"Archives of Gerontology Geriatrics"},{"issue":"2","key":"10.1016\/j.jflm.2013.02.007_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00228-009-0751-3","article-title":"Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes","volume":"66","author":"Gallelli","year":"2010","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.jflm.2013.02.007_bib17","first-page":"70","article-title":"High plasma homocysteine and low serum folate levels induced by antiepileptic drugs in down syndrome","volume":"18","author":"Siniscalchi","year":"2012","journal-title":"JODD"},{"issue":"1","key":"10.1016\/j.jflm.2013.02.007_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/0091270010365552","article-title":"Capecitabine-induced, rapid decrease of renal function due to drug dispensing error in a hospital pharmacy","volume":"51","author":"Di Mizio","year":"2011","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.jflm.2013.02.007_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jflm.2012.04.026","article-title":"A\u00a0case of adverse drug reaction induced by dispensing error","author":"Gallelli","year":"2012","journal-title":"Journal of Forensic and Legal Medicine"},{"issue":"3","key":"10.1016\/j.jflm.2013.02.007_bib20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1345\/aph.1K405","article-title":"Venlafaxine-propafenone interaction resulting in hallucinations and psychomotor agitation","volume":"42","author":"Gareri","year":"2008","journal-title":"Annals of Pharmacotherapy"},{"issue":"12","key":"10.1016\/j.jflm.2013.02.007_bib21","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1345\/aph.1P335","article-title":"Phenobarbital\/lamotrigine coadministration-induced blood dyscrasia in a patient with epilepsy","volume":"44","author":"Siniscalchi","year":"2010","journal-title":"Annals of Pharmacotherapy"},{"issue":"8","key":"10.1016\/j.jflm.2013.02.007_bib22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1358\/dot.2012.48.8.1841300","article-title":"Important drug interactions in patients with rheumatic disorders: interactions of glucocorticoids, immunosuppressants and antimalarial drugs","volume":"48","author":"Hromadkova","year":"2012","journal-title":"Drugs Today (Barc)"},{"issue":"5","key":"10.1016\/j.jflm.2013.02.007_bib23","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000235731","article-title":"Combination of captopril and allopurinol retards fructose-induced metabolic syndrome","volume":"30","author":"Roncal","year":"2009","journal-title":"American Journal of Nephrology"},{"key":"10.1016\/j.jflm.2013.02.007_bib24","doi-asserted-by":"crossref","first-page":"480642","DOI":"10.1155\/2011\/480642","article-title":"Cyclosporine: a commentary on brand versus generic formulation exchange","volume":"2011","author":"Singh","year":"2011","journal-title":"Journal of Transplantation"},{"issue":"4","key":"10.1016\/j.jflm.2013.02.007_bib25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/j.1875-9114.2012.01099.x","article-title":"Efficacy and safety of innovator versus generic drugs in patients with epilepsy: a systematic review","volume":"32","author":"Talati","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.jflm.2013.02.007_bib26","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1345\/aph.1K539","article-title":"Role of CYP3A5 in abnormal clearance of methadone","volume":"42","author":"De Fazio","year":"2008","journal-title":"The Annals of Pharmacotherapy"},{"key":"10.1016\/j.jflm.2013.02.007_bib27","article-title":"Skin rash associated with generic itraconazole administration","author":"De Vuono","year":"2012","journal-title":"Journal of Forensic and Legal Medicine"}],"container-title":["Journal of Forensic and Legal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1752928X13000267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1752928X13000267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:06:47Z","timestamp":1761696407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1752928X13000267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1752928X13000267"],"URL":"https:\/\/doi.org\/10.1016\/j.jflm.2013.02.007","relation":{},"ISSN":["1752-928X"],"issn-type":[{"value":"1752-928X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lack of efficacy during the switch from brand to generic allopurinol","name":"articletitle","label":"Article Title"},{"value":"Journal of Forensic and Legal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jflm.2013.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.","name":"copyright","label":"Copyright"}]}}